Therefore, the responsibility of Proteintech Group is to provide the research of various antibodies and related products with the highest quality possible, so that researchers can focus on their creativity, skills, efforts and funds without worrying about the quality of the reagents used. We also promise to provide them at the lowest possible cost, because we know that every dollar of research funding is the result of the hard work of researchers. They earned every dollar we saved.
As a silent partner in your research career, you can rely on us to solve your supply and technical needs for antibodies and antibody-related products. We know that we will succeed only if you succeed.
Proteintech Group provides various polyclonal and monoclonal antibodies for your research. Each antibody has been thoroughly tested and can be used for immunoprecipitation, immunoblotting and immunohistochemistry, so you can use it with confidence. Knowing that each antibody has its unique application and characteristics, we also provide customers with complete technical support and detailed instructions for each application. In order to maximize your research flexibility, we promise the following services.
Antibodies and antibody-related products used in research, biotechnology and clinical diagnosis constitute a huge but unsaturated market in the world, and show a rapid growth trend. In the United States, only the National Institutes of Health received $1700 million in federal funding, of which $1700 million, or 10%, was used for antibodies and related reagents. Many private pharmaceutical companies spend more money on antibodies and related products. Another growing market is the protein Group Project (a project to identify and describe all human protein and its functions), especially in the post-genome project period. Antibody is the only reagent to solve most problems in the project of Human protein Group at present. It is estimated that about 300,000 different anti-human protein antibodies will be needed, and only10,000 antigen specificity is available.
The task of protein Technology Group is to design, develop and sell antibodies and antibody chips in the field of biological research. The antibody will fill the current market, and its potential sales will be at least $65,438+$700 million. The price of each product should attract researchers and emphasize the lowest cost and convenience.
The production and sales procedures have been tested. The research forecast shows that the initial investment is $2 million, and the company expects sales of $24 million and net profit of about $20 million in the third year. The company expects to have revenue of $38 million by the fifth year. The company will be self-sufficient in the first year, and be able to make ends meet by relying entirely on antibody production and sales between the first year and the second year.
In the next five years, the estimated market of protein Group's engineering products will reach 40 billion dollars. Proteintech Group is currently developing an antibody chip S (a group of thousands of antibodies arranged in an array to quickly identify and quantify known or unknown protein in a mixture (such as blood), which is a key product in this market. It has its advantages.